This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aorticvalve system (Xcor system, Saint Medical Technology, Inc., of patients showedmild paravalvular leakage, and all 125 (100%) patients were in New York Heart Association ClassII.
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. and Lynn C.
BACKGROUND:Data concerning the outcomes of transcatheter aorticvalve replacement in type 0 bicuspid aorticstenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2%
Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aorticstenosis (AS) prior to transcatheter aorticvalve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. ±15.8 ±15.1 mm Hg, p value: 0.0079). to 94.8%)). to 94.8%)).
BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aorticvalve replacement (SAVR) in patients with bicuspid aorticvalve (BAV) aorticstenosis (AS) versus patients with tricuspidaorticvalve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).
Background Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspidvalves. It is unknown whether MI also induces pathological remodelling of the aorticvalve and alters aorticstenosis (AS) progression. vs –0.04±0.04 cm 2 /m 2 /year; p=0.004).
Patients with bicuspid aorticvalves (BAV) are predisposed to the development of aorticstenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aorticvalve replacement (TAVR) versus surgical aorticvalve replacement (SAVR) in patients with BAV.
Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aorticvalve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The proportion of SAVR patients increased in the <65yr patient group (26.2%
Standalone performance for significant major valve disease pathology (aorticstenosis and regurgitation and mitral and tricuspid regurgitation) had a 93 percent sensitivity and 93 percent specificity.
Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aorticvalve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD).
Assessment of fluid overload identifies aorticstenosis (AS) patients at high risk and treatment of fluid overload may potentially improve the post-interventional clinical course. TAVI, transcatheter aorticvalve implantation. FO by BIS was defined as ≥1.0 L L = euvolaemia).
Proposed approach for clinical management and therapeutic optimization in patients with heart failure with reduced ejection fraction and low blood pressure. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.
Usual structures imaged in this view are the right ventricular free wall and outflow region, interventricular septum, aorta, and aorticvalve, left ventricular outflow tract, anterior and posterior mitral leaflets, left ventricular cavity, posterior wall of left ventricle and left atrium. Apical four chamber view is illustrated here.
Objectives Grading the severity of moderate mixed aorticstenosis and regurgitation (MAVD) is challenging and the disease poorly understood. Methods Moderate MAVD was defined as coexisting moderate aorticstenosis (aorticvalve area (AVA) 1.0–1.5 –1.5 –0.6 –1.5 –0.6
Background Bicuspid aorticvalve (BAV) is often associated with a concomitant aortopathy. However, few studies have evaluated the effect of the aorticvalve (AV) phenotype on the rate of dilation of the aorta. Baseline and last follow-up visit measurements were used to assess the annualised change.
Objective CT aorticvalve calcium score (AVC score ) and density (AVC density ) thresholds have been recommended for aorticstenosis (AS) severity assessment in tricuspidaorticvalve (TAV). We aimed to compare AVC score and AVC density in bicuspid aorticvalve (BAV) versus TAV.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
AF, atrial fibrillation; LAVI, left atrial volume index; RA, right atrial; RV, right ventricular; sPAP, systolic pulmonary artery pressure; SVI, stroke volume index; TR, tricuspid regurgitation. Aims Paradoxical low-flow, low-gradient aorticstenosis (pLFLG AS) may represent a diagnostic challenge, and its pathophysiology is complex.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content